Submitted by Anonymous (not verified) on 19 July 2024 - 14:45
Opinion/decision on a Paediatric investigation plan (PIP): Retsevmo, Selpercatinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0133/2023
Source: